Cannabis Freedom Index
← History

Medical 🇸🇮 Slovenia

Slovenia permits registered cannabinoid medicines

Doctors could prescribe registered cannabinoid medicines after a new drug-classification decree took effect. The government approved the change on 19 June 2014, following debate over a citizen cannabis bill; cannabis itself remained controlled.[1][2]

Index score

2122

+1 point

The story

Slovenia opened a prescription route for registered cannabinoid medicines through a drug-classification change approved on 19 June 2014.[1] The decree was published the following day and took effect fifteen days later, on 5 July.[2]

Patients had pressed for access

The Human Rights Ombudsman’s report for 2013 describes a person with a chronic illness who said cannabis helped and wanted to use it without fearing the police.[3] The Ombudsman asked the Health Ministry to explain what it was doing, while recognising that medical effectiveness needed professional assessment.[3]

The ministry reported that the Drugs Commission had discussed cannabis in June 2013 and sought opinions from six medical boards.[3] By its December response, only the psychiatry board had replied, opposing medical use and pointing to psychiatric risks.[3] The report therefore records a debate still taking place during 2013.[3]

A citizen bill preceded the decree

Civil society submitted a cannabis bill in December 2013 seeking medical permission.[1] Parliament rejected the bill, and the government used the classification decree to open access to registered cannabinoid medicines instead.[1]

NIJZ explained that doctors could prescribe these medicines for conditions where effectiveness was demonstrated, while cannabis itself remained controlled.[1] Its guidance directed patients toward medical advice and warned against abandoning prescribed treatment because of claims that cannabis could treat every disease.[1]

The change used medicine regulation

The decree divided controlled substances into three groups according to health risks and use, with the schedules forming part of the instrument.[2] It replaced the earlier classification decree and its amendments, including the 2013 amendment.[2] The prescription change thus operated through the existing medicine and controlled-drug framework.[1][2]

For patients, the immediate distinction was between a registered cannabinoid medicine prescribed by a doctor and cannabis obtained outside that route.[1] The decision did not authorise growing a personal medical crop.[1]

Pharmacy preparations followed

NIJZ’s later report on medicine consumption describes registered medicines, specially imported medicines and compounded preparations as access routes.[4] Its incomplete pharmacy returns for 2024 recorded 1,666 prescriptions and 2,091 compounded cannabinoid preparations.[4] The same report described flower and standardised extracts as permitted but not yet routinely used.[4]

The 2025 medical and scientific cannabis law later provided a separate domestic production framework, followed in the Slovenia profile.[5]

Score by segment 0 to 10

  1. Possession · 25%3 3
  2. Personal cultivation · 25%1 1
  3. Punishment & enforcement · 20%4 4
  4. Sharing & gifting · 10%1 1
  5. Consumption · 10%2 2
  6. Legal access · 10%0 1+1

The bar shows the score after the change; the tick marks where it stood before. Slovenia's scores have changed again since.

References

  1. NIJZ and Health Ministry — Cannabis in medicinePublished 19 June 2014; citizen bill and government decisionarchived
  2. Slovenia Official Gazette — Drug-classification decree, 2014Gazette 45/2014, published 20 June; article 5, effective 5 Julyarchived
  3. Slovenian Human Rights Ombudsman — Annual report for 2013PDF pp. 120–121, Using cannabis for medical purposesarchived
  4. NIJZ — Prescription medicine consumption in Slovenia in 2024Printed p. 163; cannabinoid preparations and pharmacy returnsarchived
  5. Official Gazette — Medical and Scientific Cannabis Act, 2025archived

Checked. The date and the event were compared with a source that was read. The score before the change is an editorial estimate.

    ↑↓ to move, ↵ to open.